Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on behalf of ALWP-EBMT

BACKGROUND: Experience using post-transplant cyclophosphamide (PT-Cy) as graft-versus-host disease (GVHD) prophylaxis in allogeneic stem cell transplantation (HSCT) from matched sibling donors (MSD) or unrelated donors (UD) is limited and with controversial results. The study aim was to evaluate PT-...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Hematol Oncol
Asıl Yazarlar: Ruggeri, Annalisa, Labopin, Myriam, Bacigalupo, Andrea, Afanasyev, Boris, Cornelissen, Jan J., Elmaagacli, Ahmet, Itälä-Remes, Maija, Blaise, Didier, Meijer, Ellen, Koc, Yener, Milpied, Noel, Schouten, Harry C., Kroeger, Nicolaus, Mohty, Mohamad, Nagler, Arnon
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2018
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5855999/
https://ncbi.nlm.nih.gov/pubmed/29544522
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-018-0586-4
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller